Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thaisa Kowalski Furlan"'
Autor:
Thaisa Kowalski Furlan, Marcello Imbrizi, Daniela Magro, Paula C. Senger de Castro, Rodrigo Bremer Nones, Eron Fabio Miranda, Paulo G. Kotze
Publikováno v:
Journal of Coloproctology, Vol 44, Iss 03, Pp e187-e195 (2024)
Introduction and Objectives Certolizumab Pegol (CZP) is an anti-TNF agent approved in Brazil for Crohn's disease (CD). There is a lack of data in Brazil and Latin America detailing real-world experiences with CZP. The primary objective was clinical r
Externí odkaz:
https://doaj.org/article/824343b1774646e0be3b27e0774e6b7c
Autor:
Paula Cenira Senger de CASTRO, Daniéla Oliveira MAGRO, Rodrigo Bremer NONES, Thaisa Kowalski FURLAN, Eron Fábio MIRANDA, Paulo Gustavo KOTZE
Publikováno v:
Arquivos de Gastroenterologia (2022)
ABSTRACT Background: Real-world data on the use of Ustekinumab (UST) in Brazilian and Latin American patients with Crohn’s disease (CD) are scarce. Objective: The primary endpoint was assessment of clinical remission at weeks 8 and 52, and secondar
Externí odkaz:
https://doaj.org/article/6b948e4be8ae419ea2b646779c7add41
Autor:
Thaisa Kowalski Furlan, Marcello Imbrizi Rabello, Daniela Oliveira Magro, Paula Cenira Senger de Castro, Rodrigo Bremer Nones, Marcela Rocha Loures, Eron Fabio Miranda, Paulo Gustavo Kotze
Publikováno v:
70° Congresso Brasileiro de Coloproctologia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a4cc5dc1afb2424ce42e68b92c4a792
https://doi.org/10.1055/s-0043-1764563
https://doi.org/10.1055/s-0043-1764563
Autor:
Ligia Yukie Sassaki, Daniela Oliveira Magro, Rogerio Saad-Hossne, Julio Pinheiro Baima, Cristina Flores, Lucianna Motta Correia, Lívia Medeiros Soares Celani, Maria De Lourdes De Abreu Ferrari, Patricia Zacharias, Marley Ribeiro Feitosa, Carlos Henrique Marques Dos Santos, Manoel Alvaro De Freitas Lins Neto, Abel Botelho Quaresma, Sergio Figueiredo De Lima Junior, Graciana Bandeira Salgado De Vasconcelos, Ornella Sari Cassol, Arlene Dos Santos Pinto, Gustavo Kurachi, Francisco de Assis Goncalves Filho, Rodrigo Galhardi Gasparini, Thaísa Kowalski Furlan, Wilson Roberto Catapani, Cláudio Saddy Rodrigues Coy, Vivian De Souza Menegassi, Marilia Majeski Colombo, Renata de Sá Brito Fróes, Fabio Vieira Teixeira, Antonio Carlos Moraes, Genoile Oliveira Santana, José Miguel Luz Parente, Eduardo Garcia Vilela, Natália Sousa Freitas Queiroz, Paulo Gustavo Kotze, GEDIIB (Brazilian Study Group of IBD)
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Anti-TNF therapy represented a landmark in medical treatment of ulcerative colitis (UC). There is lack of data on the efficacy and safety of these agents in Brazilian patients. The present study aimed to analyze rates of clinical
Externí odkaz:
https://doaj.org/article/986b066f4ae94bb29816a88ce557c4d0